Literature DB >> 15542432

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

Nan Tang1, Lianchun Wang, Jeffrey Esko, Frank J Giordano, Yan Huang, Hans-Peter Gerber, Napoleone Ferrara, Randall S Johnson.   

Abstract

We deleted the hypoxia-responsive transcription factor HIF-1alpha in endothelial cells (EC) to determine its role during neovascularization. We found that loss of HIF-1alpha inhibits a number of important parameters of EC behavior during angiogenesis: these include proliferation, chemotaxis, extracellular matrix penetration, and wound healing. Most strikingly, loss of HIF-1alpha in EC results in a profound inhibition of blood vessel growth in solid tumors. These phenomena are all linked to a decreased level of VEGF expression and loss of autocrine response of VEGFR-2 in HIF-1alpha null EC. We thus show that a HIF-1alpha-driven, VEGF-mediated autocrine loop in EC is an essential component of solid tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542432     DOI: 10.1016/j.ccr.2004.09.026

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  210 in total

1.  Loss of endothelial-ARNT in adult mice contributes to dampened circulating proangiogenic cells and delayed wound healing.

Authors:  Yu Han; Jiayi Tao; Alla Gomer; Diana L Ramirez-Bergeron
Journal:  Vasc Med       Date:  2014-11-14       Impact factor: 3.239

2.  Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells.

Authors:  Kakali Sarkar; Sergio Rey; Xianjie Zhang; Raul Sebastian; Guy P Marti; Karen Fox-Talbot; Amanda V Cardona; Junkai Du; Yee Sun Tan; Lixin Liu; Frank Lay; Frank J Gonzalez; John W Harmon; Gregg L Semenza
Journal:  Cardiovasc Res       Date:  2011-10-25       Impact factor: 10.787

3.  Skin graft take rates, granulation, and epithelialization: dependence on myeloid cell hypoxia-inducible factor 1alpha.

Authors:  Emre Vural; Maaike Berbée; Alison Acott; Ross Blagg; Chun-Yang Fan; Martin Hauer-Jensen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-07

4.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

5.  PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.

Authors:  Peter Noy; Hannah Williams; Anyaporn Sawasdichai; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

6.  Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice.

Authors:  Sun Hee Yim; Yatrik Shah; Shuhei Tomita; H Douglas Morris; Oksana Gavrilova; Gilles Lambert; Jerrold M Ward; Frank J Gonzalez
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

7.  P450 in the angiogenesis affair: the unusual suspect.

Authors:  Alexander V Ljubimov; Maria B Grant
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

8.  The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.

Authors:  Qin Yan; Steven Bartz; Mao Mao; Lianjie Li; William G Kaelin
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

9.  Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006).

Authors:  Danielle A Murphy; Sosina Makonnen; Wiem Lassoued; Michael D Feldman; Christopher Carter; William M F Lee
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function.

Authors:  Laura E Crotty Alexander; Kathryn Akong-Moore; Stephanie Feldstein; Per Johansson; Anh Nguyen; Elisa K McEachern; Shari Nicatia; Andrew S Cowburn; Joshua Olson; Jae Youn Cho; Hart Isaacs; Randall S Johnson; David H Broide; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-12-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.